The global High Content Screening/Imaging market is expected to be around US$ 1.80 Billion by 2028 at a CAGR of 10% in the given forecast period.
High-content screening (HCS), is a methodology that’s employed in a research project and drug discovery to spot substances like small molecules, peptides, or RNAi that alter the makeup of a cell in the desired manner.
The factors expected to drive the expansion of the market are rising want for cost containment in pharmaceutical R&D, growth in funding for cellular analysis, and technological advancements in HCS solutions throughout the forecast amount. The increasing range of contract analysis organizations providing HCS outsourcing services and application of HCS in personalized drugs supply significant growth opportunities within the HCS market. The rising adoption of label-free technologies and growing specialize in stem cell analysis are the key trends within the HCS market.
Market Insights
The global High Content Screening/Imaging market is segregated on the basis of Component as Instrument or Platform, Imaging Device, Cytometers, Plate Reader, Light Sources, Detectors/Sensors, Liquid Handling Instruments, Consumables (Reagents and Kits), Software and Analytics, Store Image and Database Management Software by Thermo Fisher Scientific, Based on End-User Industry the global High Content Screening/Imaging market is segmented in Academics, Laboratories and Pathology Centers, and Companies (Biotechnology, Pharmaceutical and CRO).
Based on Application, the global High Content Screening/Imaging market is segmented in Molecular Diagnosis, Oncology, Drug Discovery, Toxicity Studies, Acute Toxicity Studies, Subchronic Toxicity Studies, Chronic Toxicity, Neuroscience, Compound Profiling, Application B10.
The global High Content Screening/Imaging market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The High Content Screening/Imaging market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Albany Molecular Research, Inc. (Amri), Aurelia Bioscience Ltd., Axxam Spa, Becton, Dickinson And Co., Biotek Instruments, Inc., Charles River, Corning, Inc., Creative Biolabs, Curiox Biosystems, Inc., Cytoo SA, and others are among the major players in the global High Content Screening/Imaging market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The High Content Screening/Imaging Market has been segmented as below:
High Content Screening/Imaging Market, By Component
High Content Screening/Imaging Market, By End-User Industry
High Content Screening/Imaging Market, By Application
High Content Screening/Imaging Market, By Region
High Content Screening/Imaging Market, By Company
The report covers:
Report Scope:
The global High Content Screening/Imaging market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global High Content Screening/Imaging market share. Major industry players with significant revenue share include lbany Molecular Research, Inc. (Amri), Aurelia Bioscience Ltd., Axxam Spa, Becton, Dickinson And Co., Biotek Instruments, Inc., Charles River, Corning, Inc., Creative Biolabs, Curiox Biosystems, Inc., Cytoo SA, and others.
Reasons to Buy this Report:
Customization
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Haemodialysis and Peritoneal Dialysis Market
1. Introduction
1.1 Key Insights
1.2 Report Overview
1.3 Markets Covered
1.4 Stakeholders
2. Research Methodology
2.1 Research Scope
2.2 Market Research Process
2.3 Research Data Analysis
2.4.1 Secondary Research
2.4.2 Primary Research
2.4.3 Models for Estimation
2.5 Market Size Estimation
2.5.1 Bottom-Up Approach – Segmental Market Analysis
2.5.2 Top-Down Approach – Parent Market Analysis
3. Executive Summary
4. Market Overview
4.1 Introduction
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Challenges
4.2 Porter’s Five Force Analysis
5. High Content Screening/Imaging Market, By Component
5.1 Introduction
5.2 Instrument or Platform
5.2.1 Market Overview
5.2.2 Market Size and Forecast
5.3 Imaging Device
5.3.1 Market Overview
5.3.2 Market Size and Forecast
5.4 Cytometers
5.4.1 Market Overview
5.4.2 Market Size and Forecast
5.5 Plate Reader
5.5.1 Market Overview
5.5.2 Market Size and Forecast
5.6 Light Sources
5.6.1 Market Overview
5.6.2 Market Size and Forecast
5.7 Detectors/Sensors
5.7.1 Market Overview
5.7.2 Market Size and Forecast
5.8 Liquid Handling Instruments
5.8.1 Market Overview
5.8.2 Market Size and Forecast
5.9 Consumables (Reagents and Kits)
5.9.1 Market Overview
5.9.2 Market Size and Forecast
5.10 Software and Analytics
5.10.1 Market Overview
5.10.2 Market Size and Forecast
5.11 Store Image and Database Management Software by Thermo Fisher Scientific
5.11.1 Market Overview
5.11.2 Market Size and Forecast
6. High Content Screening/Imaging Market, By End-User Industry
6.1 Introduction
6.2 Academics
6.2.1 Market Overview
6.2.2 Market Size and Forecast
6.3 Laboratories and Pathology Centers
6.3.1 Market Overview
6.3.2 Market Size and Forecast
6.4 Companies (Biotechnology, Pharmaceutical and CRO)
6.4.1 Market Overview
6.4.2 Market Size and Forecast
7. High Content Screening/Imaging Market, By Application
7.1 Introduction
7.2 Molecular Diagnosis
7.2.1 Market Overview
7.2.2 Market Size and Forecast
7.3 Oncology
7.3.1 Market Overview
7.3.2 Market Size and Forecast
7.4 Drug Discovery
7.4.1 Market Overview
7.4.2 Market Size and Forecast
7.5 Toxicity Studies
7.5.1 Market Overview
7.5.2 Market Size and Forecast
7.6 Acute Toxicity Studies
7.6.1 Market Overview
7.6.2 Market Size and Forecast
7.7 Subchronic Toxicity Studies
7.7.1 Market Overview
7.7.2 Market Size and Forecast
7.8 Chronic Toxicity
7.8.1 Market Overview
7.8.2 Market Size and Forecast
7.9 Neuroscience
7.9.1 Market Overview
7.9.2 Market Size and Forecast
7.10 Compound Profiling
7.10.1 Market Overview
7.10.2 Market Size and Forecast
8. High Content Screening/Imaging Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 North America High Content Screening/Imaging, By Component
8.2.2 North America High Content Screening/Imaging, By End-User Industry
8.2.3 North America High Content Screening/Imaging, By Application
8.3 Europe
8.3.1 Europe High Content Screening/Imaging, By Component
8.3.2 Europe High Content Screening/Imaging, By End-User Industry
8.3.3 Europe High Content Screening/Imaging, By Application
8.4 Asia-Pacific
8.4.1 Asia-Pacific High Content Screening/Imaging, By Component
8.4.2 Asia-Pacific High Content Screening/Imaging, By End-User Industry
8.4.3 Asia-Pacific High Content Screening/Imaging, By Application
8.5 Rest of the World
8.5.1 Rest of the World High Content Screening/Imaging, By Component
8.5.2 Rest of the World High Content Screening/Imaging, By End-User Industry
8.5.3 Rest of the World High Content Screening/Imaging, By Application
9. Competitive Insights
9.1 Key Insights
9.2 Company Market Share Analysis
9.3 Strategic Outlook
9.3.1 Mergers & Acquisitions
9.3.2 New Product Development
9.3.3 Portfolio/Production Capacity Expansions
9.3.4 Joint Ventures, Collaborations, Partnerships & Agreements
9.3.5 Others
10. Company Profiles
10.1 lbany Molecular Research, Inc. (Amri)
10.1.1 Company Overview
10.1.2 Product/Service Landscape
10.1.3 Financial Overview
10.1.4 Recent Developments
10.2 Aurelia Bioscience Ltd.
10.2.1 Company Overview
10.2.2 Product/Service Landscape
10.2.3 Financial Overview
10.2.4 Recent Developments
10.3 Axxam Spa
10.3.1 Company Overview
10.3.2 Product/Service Landscape
10.3.3 Financial Overview
10.3.4 Recent Developments
10.4 Becton, Dickinson And Co.
10.4.1 Company Overview
10.4.2 Product/Service Landscape
10.4.3 Financial Overview
10.4.4 Recent Developments
10.5 Biotek Instruments, Inc.
10.5.1 Company Overview
10.5.2 Product/Service Landscape
10.5.3 Financial Overview
10.5.4 Recent Developments
10.6 Charles River
10.6.1 Company Overview
10.6.2 Product/Service Landscape
10.6.3 Financial Overview
10.6.4 Recent Developments
10.7 Corning, Inc.
10.7.1 Company Overview
10.7.2 Product/Service Landscape
10.7.3 Financial Overview
10.7.4 Recent Developments
10.8 Creative Biolabs
10.8.1 Company Overview
10.8.2 Product/Service Landscape
10.8.3 Financial Overview
10.8.4 Recent Developments
10.9 Curiox Biosystems, Inc.
10.9.1 Company Overview
10.9.2 Product/Service Landscape
10.9.3 Financial Overview
10.9.4 Recent Developments
10.10 Cytoo Sa
10.10.1 Company Overview
10.10.2 Product/Service Landscape
10.10.3 Financial Overview
10.10.4 Recent Developments
The High Content Screening/Imaging Market has been segmented as below:
High Content Screening/Imaging Market, By Component
High Content Screening/Imaging Market, By End-User Industry
High Content Screening/Imaging Market, By Application
High Content Screening/Imaging Market, By Region
High Content Screening/Imaging Market, By Company
SUBSCRIBE TO OUR NEWSLETTERS
